A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics ...
Transposable elements play a significant role in regulating gene expression and genome architecture, influencing development, ...
Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen ...
APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...
News-Medical.Net on MSN
Bowhead whale’s secret to long life revealed: precision DNA repair may hold clues for human aging
Researchers discovered that bowhead whales achieve extraordinary longevity and cancer resistance through highly efficient and precise DNA repair mechanisms. A whale-specific protein, CIRBP, enhances ...
PRIMETIMER on MSN
Complete cast breakdown of Pluribus season 1: Who plays who & where you’ve heard or seen them before
In Pluribus, Rhea Seehorn stars as Carol Sturka—a disillusioned romance novelist who becomes “the most miserable person on ...
Indian Defence Review on MSN
This Long-Ignored DNA May Be the Key to Wiping Out Drug-Resistant Blood Cancer
Long dismissed as evolutionary leftovers, segments of DNA once labeled “junk” may now offer a novel way to kill off deadly blood cancers. Scientists have discovered that these silent sequences, when ...
An RNA-based therapeutic approach led to transient activation of telomerase activity in a model of pulmonary fibrosis. A new report suggests that RNA-based human telomerase reverse transcriptase ...
Medpage Today on MSN
Investigational Combination Shows Promise in Chronic Hepatitis D
WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results